Trial Profile
Azilect In Wearing-Off (AIWO) Non-interventional Study on Efficacy and Tolerability of Rasagiline (1mg/d) add-on in Ambulatory Parkinson's Disease Patients With Wearing-off Symptoms Diagnosed by Wearing-off Questionnaire (WOQ-32)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Sep 2016
Price :
$35
*
At a glance
- Drugs Rasagiline (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms AIWO
- Sponsors Teva Pharmaceutical Industries
- 13 Mar 2015 New trial record